(Q46057014)

19 December 2017

title

Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study (English)

1 reference

19 December 2017

1 reference

1 reference

anemia of prematurity

1 reference

Shannon KM

1

1 reference

19 December 2017

Mentzer WC

2

1 reference

19 December 2017

Abels RI

3

1 reference

19 December 2017

Freeman P

4

1 reference

19 December 2017

Newton N

5

1 reference

19 December 2017

Thompson D

6

1 reference

19 December 2017

Sniderman S

7

1 reference

19 December 2017

Ballard R

8

1 reference

19 December 2017

Phibbs RH

9

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 June 1991

1 reference

19 December 2017

The Journal of Pediatrics

published in

1 reference

19 December 2017

volume

118

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

949-955

1 reference

19 December 2017

The anemia of prematurity. Factors governing the erythropoietin response

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Anemia of prematurity: determinants of the erythropoietin response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Postnatal changes in erythropoietin levels in untransfused premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Circulating erythroid progenitors in the anemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Enumeration of reticulocytes using fluorescence-activated flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Life-span of the fetal red blood cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Postnatal changes in serum immunoreactive erythropoietin in relation to hypoxia before and after birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

Prediction of the need for transfusion during anemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2982217-6

10.1016/S0022-3476(05)82217-6

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017